Literature DB >> 9195063

Influenza among hospitalized adults with leukemia.

H M Yousuf1, J Englund, R Couch, K Rolston, M Luna, J Goodrich, V Lewis, N Q Mirza, M Andreeff, C Koller, L Elting, G P Bodey, E Whimbey.   

Abstract

Influenza is one of the most important respiratory diseases of mankind, yet scant data exist concerning the frequency and clinical course of influenza in severely immunocompromised adults. From October 1993 to September 1994, we cultured the respiratory secretions of all adults with leukemia who were hospitalized with an acute respiratory illness at The University of Texas M.D. Anderson Cancer Center in Houston. During a 9-week period from 29 November 1993 to 29 January 1994, influenza virus type A (H3N2) was isolated from 15 (33%) of these 45 hospitalized adults. Twelve (80%) of the cases of influenza were associated with pneumonia, and four patients (33%) with pneumonia died. Patients who died tended to have received chemotherapy more recently and to be more myelosuppressed. Autopsy examination in two cases revealed histopathologic changes consistent with viral pneumonia. During community outbreaks, influenza is a frequent cause of serious respiratory disease in hospitalized adults with leukemia. Effective prophylactic and therapeutic regimens need to be defined for immunocompromised patients.

Entities:  

Mesh:

Year:  1997        PMID: 9195063     DOI: 10.1086/513648

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Impact of sample type on rapid detection of influenza virus A by cytospin-enhanced immunofluorescence and membrane enzyme-linked immunosorbent assay.

Authors:  M L Landry; S Cohen; D Ferguson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.

Authors:  A Rañó; C Agustí; P Jimenez; J Angrill; N Benito; C Danés; J González; M Rovira; T Pumarola; A Moreno; A Torres
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

Review 3.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

4.  Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.

Authors:  Silvana Carr; Natalia A Ilyushina; John Franks; Elisabeth E Adderson; Miguela Caniza; Elena A Govorkova; Robert G Webster
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

Review 5.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

6.  Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011-2015.

Authors:  Jennifer P Collins; Angela P Campbell; Kyle Openo; Monica M Farley; Charisse Nitura Cummings; Mary Hill; William Schaffner; Mary Lou Lindegren; Ann Thomas; Laurie Billing; Nancy Bennett; Nancy Spina; Marisa Bargsten; Ruth Lynfield; Seth Eckel; Patricia Ryan; Kimberly Yousey-Hindes; Rachel Herlihy; Pam Daily Kirley; Shikha Garg; Evan J Anderson
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

7.  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.

Authors:  Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Brett W Jagger; Zong-Mei Sheng; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 8.  Seasonal influenza vaccine in immunocompromised persons.

Authors:  Mohammad Bosaeed; Deepali Kumar
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

9.  Response to influenza immunisation during treatment for cancer.

Authors:  J C Chisholm; T Devine; A Charlett; C R Pinkerton; M Zambon
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

Review 10.  How I treat influenza in patients with hematologic malignancies.

Authors:  Corey Casper; Janet Englund; Michael Boeckh
Journal:  Blood       Date:  2009-12-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.